1 2 3 "Inside Clavicular's Thirsty Tour of New York City"
Ravi, N., Choday, S., Shantha Kumar, V., Kc, A., Parisapogu, A., Ojinna, B
Refine Her Is Not Just a Program Its a Community Beyond the clinical care, Refine Her members gain access to a community of women navigating the same transitions exclusive events, open conversations, education, and the support of physicians who understand womens unique health journeys
The weight loss market has no signs of slowing down, with some reports suggesting there are nearly 160 obesity drugs currently in development by big pharma companies
Nat Med 2015;21:2736.PubMed 59
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
